Skip to main content
Have a personal or library account? Click to login
Prognostic Utility Of Novel Biomarkers in Aortic Valve Stenosis Cover

Prognostic Utility Of Novel Biomarkers in Aortic Valve Stenosis

Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
Volume 73 (2019): Issue 2 (May 2019)
By: ,  ,  ,  ,  ,  ,   and    
Open Access
|Apr 2019
Authors

Authors

Pēteris Tretjakovs

peteris.tretjakovs@rsu.lv

Faculty of Medicine, Rīga Stradiņš University, Rīga, Latvia

Juris Hofmanis

Faculty of Medicine, Rīga Stradiņš University, Rīga, Latvia

Dace Hofmane

Faculty of Medicine, Rīga Stradiņš University, Rīga, Latvia

Gita Krieviņa

Faculty of Medicine, Rīga Stradiņš University, Rīga, Latvia

Leons Blumfelds

Faculty of Medicine, Rīga Stradiņš University, Rīga, Latvia

Vitolds Mackēvičs

Faculty of Medicine, Rīga Stradiņš University, Rīga, Latvia

Aivars Lejnieks

Faculty of Medicine, Rīga Stradiņš University, Rīga, Latvia

Guntis Bahs

Faculty of Medicine, Rīga Stradiņš University, Rīga, Latvia
DOI: https://doi.org/10.2478/prolas-2019-0016 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Journal RSS Feed
Language: English
Page range: 100 - 106
Submitted on: Nov 5, 2018
Accepted on: Jan 3, 2019
Published on: Apr 7, 2019
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Keywords:
aortic valve stenosis,
chemerin,
myeloperoxidase,
fibroblast growth factor-21,
thioredoxin reductase-1,
matrix metalloproteinase-9
Related subjects:
General interest,
Mathematics,
General mathematics

© 2019 Pēteris Tretjakovs, Juris Hofmanis, Dace Hofmane, Gita Krieviņa, Leons Blumfelds, Vitolds Mackēvičs, Aivars Lejnieks, Guntis Bahs, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 73 (2019): Issue 2 (May 2019)
Previous article
Next article